Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Donor lymphocyte infusion
Introduction
Overview
Overview
Donor lymphocyte infusion (DLI) is a form of adoptive immunotherapy used after hematopoietic stem cell transplantation. Lymphocytes from the original stem cell donor are infused, after the transplant, to augment an anti-tumor immune response or ensure that the donor stem cells remain engrafted.[1][2] Complications of DLI include acute and chronic graft-versus-host disease and bone marrow aplasia, resulting in immunosuppression and susceptibility to opportunistic infections.[3]
Notes
Notes
- ↑ Porter D, Levine JE (2006). “Graft-versus-host disease and graft-versus-leukemia after donor leukocyte infusion”. Semin. Hematol. 43 (1): 53–61. doi:10.1053/j.seminhematol.2005.09.005. PMID 16412789.
- ↑ Loren AW, Porter DL (2006). “Donor leukocyte infusions after unrelated donor hematopoietic stem cell transplantation”. Current opinion in oncology. 18 (2): 107–14. doi:10.1097/01.cco.0000208781.61452.d3. PMID 16462177.
- ↑ Luznik L, Fuchs EJ (2002). “Donor lymphocyte infusions to treat hematologic malignancies in relapse after allogeneic blood or marrow transplantation”. Cancer control : journal of the Moffitt Cancer Center. 9 (2): 123–37. PMID 11965233.Full text
References
References
- Thomas’ Hematopoietic Cell Transplantation, ed. Blume KG, Forman SJ, Appelbaum FR. Blackwell Publishers, Cambridge, MA: 2004. ISBN 1-4051-1256-5.